Filamin-A expression in triple-negative breast cancer and its clinical significance
The quest for discovering novel biomarkers of triple-negative breast cancers (TNBCs) is ongoing. By lacking expression of hormonal receptors, this aggressive subtype of breast cancer presents a clinical dilemma with early recurrence, metastases and poor survival outcome. Filamin-A is a recent novel...
Guardado en:
Autor principal: | Abderrahman Ouban |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d97f3845d79b4b17a40e3ab3cb8c6794 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma
por: Gaoda Ju, et al.
Publicado: (2021) -
The global status of research in breast cancer liver metastasis: a bibliometric and visualized analysis
por: Yanlong Shi, et al.
Publicado: (2021) -
Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer
por: Jianfeng Ding, et al.
Publicado: (2021) -
Identification of circRNA_001846 as putative non–small cell lung cancer biomarker
por: Fan Yang, et al.
Publicado: (2021) -
Development of dual‐inducible duet‐expression vectors for tunable gene expression control and CRISPR interference‐based gene repression in Pseudomonas putida KT2440
por: Rahul Gauttam, et al.
Publicado: (2021)